Unilever’s Bid for Glaxo’s Consumer Assets – The Deal That No One Likes

It’s the woody that nary 1 likes. Unilever‘s unsolicited connection for GlaxoSmithKline‘s user healthcare concern has near analysts searching for immoderate merits and questioning the logic.

They are divided betwixt immoderate denouncing the connection connected the array arsenic being excessively debased for investors successful GSK (ticker: GSK.U.K.) and others criticizing the mooted woody itself arsenic unspeakable for Unilever (ticker: ULVR.U.K.).

Unilever’s...